Pfliegler Valter Péter, Boros Enikő, Pázmándi Kitti Linda, Jakab Ágnes, Zsuga Imre, Kovács Renátó, . . . Pócsi István. (2017). Commercial strain-derived clinical Saccharomyces cerevisiae can evolve new phenotypes without higher pathogenicity.
Chicago Style (17th ed.) CitationPfliegler Valter Péter, et al. Commercial Strain-derived Clinical Saccharomyces Cerevisiae Can Evolve New Phenotypes Without Higher Pathogenicity. Wiley, 2017.
MLA idézésPfliegler Valter Péter, et al. Commercial Strain-derived Clinical Saccharomyces Cerevisiae Can Evolve New Phenotypes Without Higher Pathogenicity. 2017.
Figyelem: ezek az hivatkozások nem 100%-ban pontosak..